01.11.2007 20:05:00
|
Hercules Technology Growth Capital Announces Record Third Quarter 2007 Financial Results and Achieves Record $0.31 EPS for Net Investment Income
Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC), a premier
specialty finance company providing venture debt and equity to venture
capital and private equity backed technology and life science companies
at all stages of development, today announced its financial results for
the third quarter ended September 30, 2007.
Third Quarter 2007 Highlights:
Record net investment income before taxes during the quarter increased
by 222.2% to approximately $10.0 million, compared to approximately
$3.1 million in 3Q 2006. Net investment income per share was $0.31 for
the third quarter of 2007 compared to $0.23 per share in the third
quarter of 2006, exceeding our current dividend of $0.30 per share.
Net income more than doubled to approximately $7.2 million or $0.22
per share on approximately 32.4 million basic shares outstanding
versus approximately $1.6 million or $0.12 per share on approximately
13.7 million basic shares outstanding for the third quarter of 2006.
Commitments since inception were approximately $768.5 million.
Commitments totaled approximately $43.4 million in the quarter,
comprised of approximately $40.2 million in debt commitments and $3.2
million of equity commitments.
Fundings since inception totaled approximately $610.0 million with
funding in the quarter totaling approximately $38.4 million. Debt
funded in the quarter totaled approximately $35.2 million and equity
funding totaled $3.2 million.
Effective yield on our investment portfolio from interest and fees for
the quarter was 14.9%, representing the highest effective yield since
inception.
Hercules held warrant positions in 75 portfolio companies at the end
of the third quarter of 2007, compared to warrants in 51 companies at
the end of the third quarter of 2006.
Declared ninth dividend since inception of $0.30, payable on December
17, 2007 to shareholders of record as of November 16, 2007.
"We continue to expand our capital offering to
technology and life sciences companies and achieved another quarter of
strong results which included achieving, for the first time since our
inception, a critical milestone of generating net investment income of
$0.31 in excess of our dividend of $0.30 per share,”
said Manuel Henriquez, CEO of Hercules Technology. "We
posted record revenues and net investment income despite the traditional
seasonal summer slowdown regarding our origination efforts.” "During the third quarter, we continued to
build and expand the Hercules platform with the goal of broadening our
offerings to fulfill the needs of technology and life science companies
throughout all their stages of development from seed and emerging
growth, to expansion and established-stage of development, including
expanding into select publicly listed companies and lower middle market
companies. In the third quarter we achieved many significant goals, such
as expanding our team with the addition of two highly experienced
technology equity venture investors and one PhD to our life sciences
team, expanding our southern California presence and expanding our
product offering,” continued Henriquez.
"We also saw solid growth in U.S. venture
capital investments which reached the highest level since Q1 2001, to
$8.07 billion in the third quarter of 2007, according to Dow Jones
VentureOne. In addition, we also continue to see encouraging
liquidity of venture backed companies during the quarter, According to
the National Venture Capital Association, there were 67 venture backed
M&A deals this quarter resulting in a Dollar value twice as large as the
same period in 2006. Similarly, there were 12 IPOs during the quarter, a
50% increase over last year. Of these 12, nine were technology companies
and three were life science companies, the sectors in which Hercules is
focused,” concluded Henriquez.
Third Quarter Review and Operating Results
During the quarter, Hercules entered into agreements to provide debt
financing of approximately $40.2 million, bringing total commitments
since inception to approximately $768 million, and funded a total of
approximately $35.2 million in debt investments. The weighted average
fundings during the third quarter were approximately $13.0 million. The
difference between the total fundings and the weighted average fundings
reflects the timing of fundings occurring later in the quarter.
In addition, Hercules made equity investments totaling approximately
$3.2 million in four portfolio companies during the quarter.
Proceeds from principal repayments were approximately $36.6 million,
comprised of amortization of principal of approximately $18.3 million,
early repayments of approximately $16.3 million from four portfolio
companies, and pay downs of approximately $2.0 million on working
capital lines of credit.
During the third quarter, two portfolio companies, Sling Media and
Interwise, announced they were being acquired and Hercules recognized
approximately $1.3 million of unrealized gains from its warrant and
equity investments in these companies. The total unrealized gains
recognized to date on investments in these two portfolio companies is
approximately $2.6 million based on the estimated fair value as of
September 30, 2007.
As of September 30, 2007, Hercules had unfunded debt commitments of
approximately $107.7 million to 28 portfolio companies. Since these
commitments may expire without being drawn upon, the total commitment
does not necessarily represent future cash requirements. In addition,
the Company executed non-binding term sheets with nine prospective
portfolio companies, representing approximately $133.0 million in
proposed future commitments. These proposed investments are subject to
completion of the Company’s due diligence and
final approval process, as well as the negotiation of definitive
documentation with the prospective portfolio companies. Not all
non-binding term sheets are expected to close and do not necessarily
represent future cash requirements.
David Lund, CFO of Hercules Technology said, "Our
commitment and funding activity during the quarter was reflective of the
expected seasonal slow down in investing activities normally seen during
this period. We believe the current investment environment for
technology and life science companies will result in a significant
increase in our investment opportunities in the fourth quarter, as
evidenced by the non-binding term sheets we were engaged in at quarter
end.” Investment Portfolio
The fair value of Hercules’ investment
portfolio at quarter-end was approximately $415.6 million, representing
investments in 82 portfolio companies as compared to approximately
$237.5 million at the end of the third quarter of 2006. The fair value
of the equity portfolio was approximately $15.6 million invested in 22
portfolio companies, compared to a fair value of approximately $8.3
million invested in 13 portfolio companies at the end of the third
quarter of 2006. Hercules held warrant positions in 75 portfolio
companies, with a fair value of approximately $13.2 million. The fair
value of the warrant portfolio has increased by 44.0% as compared to
$9.2 million at September 30, 2006. These warrant holdings would allow
Hercules to invest approximately $43.7 million if such warrants are
exercised. The fair value of the loan portfolio was approximately $400.0
million invested in 82 portfolio companies compared to a fair value of
approximately $229.2 million invested in 53 portfolio companies at the
end of the third quarter 2006.
The effective yield on our debt investments during the quarter was 14.9%
and was attributed in part to higher interest charges and fees related
to loan restructurings and acceleration of fee income recognition from
early loan repayments. The overall weighted average yield to maturity on
the Company’s loan portfolio increased
slightly to approximately 12.8% as of September 30, 2007. The weighted
average yield to maturity is computed using interest rates in effect at
inception of each of the loans, and include amortization of loan
facility fees, commitment fees and market premiums or discounts over the
expected life of the debt investments, weighted by their respective
costs when averaged and based on the assumption that all contractual
loan commitments have been fully funded and held to maturity.
Income Statement
Continued growth of Hercules’ debt
investments contributed to a 100.7% increase in total investment income
to approximately $15.1 million during the third quarter of 2007, as
compared to approximately $7.5 million in the third quarter of 2006. Fee
income includes approximately $1.9 million of one-time fees, default
interest and acceleration of deferred income related to early repayments.
Interest expense and loan fees driven by borrowing activities were
approximately $972,000 during the third quarter, a decrease of
approximately 38.1% versus $1.6 million in the same quarter of the
previous year. The decrease was attributed to a lower average debt
balance of approximately $33.2 million in the third quarter of 2007 as
compared to approximately $71.1 million for the comparable period of
2006. Hercules had a weighted average cost of debt of approximately 6.5%
at September 30, 2007.
The Company’s SBA borrowings bear interest at
an interim rate of LIBOR plus 30 basis points until fixed at the semi
annual meeting of the SBA. The rate becomes fixed at the time of the SBA
pooling which generally occurs in September and March each year and is
set to the 10 year treasury rate at that time plus a spread and an
annual SBA charge, which taken together currently approximates 175 basis
points.
Total operating expenses, excluding interest expense and loan fees, for
the third quarter of 2007 were approximately $4.1 million, which is an
increase of $1.2 million, compared to $2.9 million for the third quarter
of 2006. The increase as compared to the quarter ended September 30,
2006 was primarily attributable to higher compensation expense related
to an increase in new employees and compensation-related accruals.
General and administrative expenses were $300,000 lower than the $1.7
million during the second quarter of 2007. The decrease was primarily
attributed to the absence of expenses related to portfolio company
workouts that took place in the second quarter. The general and
administrative expenses of approximately $1.4 million were steady with
the $1.4 million during the third quarter of 2006.
Net investment income before provision for income taxes for the third
quarter of 2007 was approximately $10.0 million, which represents an
increase of 222.2%, compared to approximately $3.1 million for the third
quarter of 2006. Net investment income before income taxes was 38.7% or
approximately $2.8 million higher than the second quarter of 2007. Net
investment income before provision for income taxes on a basic per share
basis during the current quarter was $0.31 per share, based upon 32.4
million basic shares outstanding, compared to $0.23 per share in the
comparable quarter of 2006 on 13.7 million basic shares outstanding.
Net realized gains of approximately $49,000 recognized during the third
quarter were attributed to gains of approximately $433,000 on the sale
of common stock in two portfolio companies offset by the realized loss
of two warrants with a cost basis of approximately $384,000 based on the
Black-Scholes value at time of the loan origination. This realized loss
was a reversal of an unrealized loss recorded in previous quarters of
2007.
Hercules recognized net unrealized depreciation on investments of
approximately $2.9 million during the third quarter of 2007. The net
unrealized depreciation was attributed to an unrealized loss of $2.0
million on the loan value of one portfolio company, a net unrealized
loss of approximately $1.2 million in the value of our public company
warrants, offset by a net unrealized gain of approximately $300,000 in
the value of our private company equity and warrant portfolio.
Dividends
The Company distributed a dividend of $0.30 per share to its
shareholders during the quarter. This distribution was the eighth
consecutive quarterly dividend paid and brings total distributions to
$2.125 per share since its initial public offering in June 2005.
The Board of Directors declared a third quarter dividend of $0.30 per
share. The dividend will be payable on December 17, 2007 to shareholders
of record as of November 16, 2007. This was the Company’s
ninth consecutive dividend declaration since its initial public
offering, and will bring the total cumulative dividend declared to date
to $2.425 per share.
The determination of the tax attributes of the Company's distributions
is made annually as of the end of the Company's fiscal year based upon
its taxable income for the full year and distributions paid for the full
year. Therefore, a determination made on a quarterly basis may not be
representative of the actual tax attributes of its distributions for a
full year. If the Company determined the tax attributes of its
distributions year-to-date as of September 30, 2007, 98.1% would be from
ordinary income and 1.9% would be a return of capital for stockholders;
however, there can be no certainty to shareholders that this
determination is representative of what the tax attributes of its 2007
distributions to shareholders will actually be. For the fiscal year
ended December 31, 2006, a portion of the distributions to the Company's
shareholders was deemed a return of capital.
Liquidity and Capital Resources
At September 30, 2007, the Company’s net
assets were approximately $389.6 million, with a net asset value per
share of $11.97 as compared $11.06 per share in the third quarter of
2006.
The Company ended the third quarter with $26.2 million in cash and cash
equivalents. Hercules $250.0 million credit facility, combined with the
$127.2 million available under the SBA program, allows it access to
$377.2 million in capital. At September 30, 2007, approximately $32.2
million was outstanding under the credit facility and $19.8 million was
outstanding under the SBA debentures, leaving approximately $325.2
available to borrow, subject to certain credit and regulatory
limitations.
Based on Hercules’ current stockholders’
equity and its SEC exemptive relief for borrowings available under the
SBA debenture program, the Company has the potential to leverage its
balance sheet in excess of $500.0 million. This figure assumes Hercules
is able to expand it existing credit facilities. The Company had
approximately $52.0 million in debt outstanding as of September 30, 2007
as compared to $33.7 million at June 30, 2007.
"At the end of the quarter our balance sheet
was levered at only 13%. We anticipate our current access to capital
combined with our projected cash flows from operations will allow us to
fund investments and operations for four to five quarters before looking
to raise capital in the equity market,” said
David Lund, CFO of Hercules Technology.
Portfolio Asset Quality and Diversification
As of September 30, 2007, grading of the debt portfolio, excluding
warrants and equity investments, was approximately as follows:
Grade 1 $20.9 million or 5.4% of the total portfolio
Grade 2 $279.3 million or 71.9% of the total portfolio
Grade 3 $80.3 million or 20.7% of the total portfolio
Grade 4 $4.1 million or 1.0% of the total portfolio
Grade 5 $4.0 million or 1.0% of the total portfolio
At September 30, 2007, the weighted average loan grade of the portfolio
was 2.20 on a scale of 1 to 5, with 1 being the highest quality,
compared with 2.16 as of June 30, 2007. Hercules’
policy is to adjust the grading on its portfolio companies as they
require additional equity capital.
Hercules’ portfolio diversification as of
September 30, 2007 was approximately as follows:
21.7% in drug discovery companies
21.2% in communications and networking companies
8.8% in software companies
8.6% in specialty pharmaceutical companies
7.8% in electronics and computer hardware companies
6.2% in semiconductor companies
4.4% in information services
3.9% in therapeutic companies
3.3% in Internet companies
2.9% in drug delivery companies
2.0% in consumer and business product companies
1.9% in energy companies
1.9% in biotechnology tools companies
1.8% in media/content/info companies
1.5% in surgical device companies
1.4% in advanced specialty material and chemical companies
0.7% in diagnostic companies
Subsequent Events
On October 26, 2007, the Company’s portfolio
company Power Medical, announced that it completed its initial public
offering of common stock, having sold 3,850,000 shares at $11.00 per
share.
Conference Call
Hercules has scheduled its 2007 third quarter financial results
conference call for November 1, 2007 at 2:00 p.m. PDT (5:00 p.m. EDT).
To listen to the call, please dial (800) 395-0708 or (913) 312-1427
approximately 10 minutes prior to the start of the call. A taped replay
will be made available approximately two hours after the conclusion of
the call and will remain available for one week. To access the replay,
please dial (888) 203-1112 or (719) 457-0820 and enter passcode 6461501.
The Hercules financial results conference call will be available via a
live webcast on the investor relations section of the Hercules website
at http://www.HerculesTech.com.
Access the website 15 minutes prior to the start of the call to download
and install any necessary audio software. An archived webcast replay
will be available on the website for approximately 90 days.
About Hercules Technology Growth Capital, Inc.:
Hercules Technology Growth Capital, Inc. is a Nasdaq traded specialty
finance company providing debt and equity growth capital to technology
and life science companies at all stages of development. Founded in
December 2003, the company primarily finances privately held companies
backed by leading venture capital and private equity firms. Hercules
invests in a broad range of ventures active in technology and life
science industries and offers a full suite of growth capital products up
and down the capital structure. The company is headquartered in Palo
Alto, Calif. and has additional offices in the Boston, Boulder, Los
Angeles and Chicago areas. Providing capital to publicly-traded or
privately-held companies backed by leading venture capital and private
equity firms involves a high degree of credit risk and may result in
potential losses of capital. For more information, please visit www.HTGC.com.
Companies interested in learning more about financing opportunities
should contact info@HTGC.com, or call
650.289.3060.
Forward-Looking Statements:
The statements contained in this release that are not purely historical
are forward-looking statements. These forward-looking statements are not
guarantees of future performance and are subject to uncertainties and
other factors that could cause actual results to differ materially from
those expressed in the forward-looking statements including, without
limitation, the risks, uncertainties and other factors we identify from
time to time in our filings with the Securities and Exchange Commission.
Although we believe that the assumptions on which these forward-looking
statements are reasonable, any of those assumptions could prove to be
inaccurate and, as a result, the forward-looking statements based on
those assumptions also could be incorrect. You should not place undue
reliance on these forward-looking statements. The forward-looking
statements contained in this release are made as of the date hereof, and
Hercules assumes no obligation to update the forward-looking statements
for subsequent events.
HERCULES TECHNOLOGY GROWTH CAPITAL, INC. CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES (unaudited)
September 30, 2007 December 31, (unaudited)
2006
Assets
Investments, at value (cost of $412,955,198 and $279,946,465,
respectively)
$
415,592,166
$
283,233,751
Deferred loan origination revenue
(5,072,929
)
(3,450,971
)
Cash and cash equivalents
26,185,643
16,404,214
Interest receivable
5,612,071
2,906,831
Other assets
3,767,521
2,048,384
Total assets
446,084,472
301,142,209
Liabilities
Accounts payable
291,563
540,376
Accrued liabilities
4,215,228
4,189,011
Short-term loans payable
32,200,000
41,000,000
Long-term loans payable
19,750,000
-
Total liabilities
56,456,791
45,729,387
Net assets
$
389,627,681
$
255,412,822
Net assets consist of:
Par value
$
32,539
$
21,927
Capital in excess of par value
393,210,864
257,234,729
Unrealized appreciation on investments
2,127,358
2,860,654
Accumulated realized losses on investments
(1,968,895
)
(1,972,014
)
Distributions in excess of investment income
(3,774,185
)
(2,732,474
)
Total net assets
$
389,627,681
$
255,412,822
Shares of common stock outstanding ($0.001 par value, 60,000,000
authorized)
32,539,413
21,927,034
Net asset value per share
$
11.97
$
11.65
HERCULES TECHNOLOGY GROWTH CAPITAL, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
Three Months Ended September 30, Nine Months Ended September 30,
2007
2006
2007
2006
Investment income:
Interest
$
13,568,843
$
6,697,291
$
34,396,381
$
18,507,661
Fees
1,571,826
846,741
3,697,996
2,311,415
Total investment income
15,140,669
7,544,032
38,094,377
20,819,076
Operating expenses:
Interest
553,466
1,420,140
3,002,716
4,455,015
Loan fees
418,660
149,677
935,080
687,158
General and administrative
1,420,055
1,436,467
4,442,223
4,040,445
Employee Compensation:
Compensation and benefits
2,404,072
1,244,993
6,358,397
3,577,313
Stock-based compensation
295,349
175,600
841,804
428,600
Amortization of restricted stock awards
5,012
-
5,012
-
Total employee compensation
2,704,433
1,420,593
7,205,213
4,005,913
Total operating expenses
5,096,614
4,426,877
15,585,232
13,188,531
Net investment income before provision for income taxes and
investment gains and losses
10,044,055
3,117,155
22,509,145
7,630,545
Provision (benefit) for income taxes
-
(345,089
)
-
643,088
Net investment income
10,044,055
3,462,244
22,509,145
6,987,457
Net realized gain (loss) on investments
49,046
(2,482,465
)
3,119
(2,570,705
)
Net increase (decrease) in unrealized appreciation on investments
(2,914,983
)
592,860
(733,296
)
3,027,251
Net realized and unrealized gain (loss)
(2,865,937
)
(1,889,605
)
(730,177
)
456,546
Net increase in net assets resulting from operations
$
7,178,118
$
1,572,639
$
21,778,968
$
7,444,003
Net investment income before provision for income taxes and
investment gains and losses per common share:
Basic
$
0.31
$
0.23
$
0.84
$
0.63
Diluted
$
0.31
$
0.23
$
0.83
$
0.62
Change in net assets per common share:
Basic
$
0.22
$
0.12
$
0.81
$
0.61
Diluted
$
0.22
$
0.11
$
0.81
$
0.61
Weighted average shares outstanding
Basic
32,427,000
13,661,000
26,864,000
12,158,000
Diluted
32,526,000
13,779,000
26,992,000
12,277,000
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Hercules Technology Growth Capital IncShsmehr Nachrichten
29.10.24 |
Ausblick: Hercules Technology Growth Capital stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
31.07.24 |
Ausblick: Hercules Technology Growth Capital öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |